- Article
Chemotherapeutic Drugs Inhibiting Topoisomerase 1 Activity Impede Cytokine-Induced and NF-κB p65-Regulated Gene Expression
- Tabea Riedlinger,
- Marek Bartkuhn,
- Tobias Zimmermann,
- Sandra B. Hake,
- Andrea Nist,
- Thorsten Stiewe,
- Michael Kracht and
- M. Lienhard Schmitz
Inhibitors of DNA topoisomerase I (TOP1), an enzyme relieving torsional stress of DNA by generating transient single-strand breaks, are clinically used to treat ovarian, small cell lung and cervical cancer. As torsional stress is generated during tra...

